Skip to main content
. 2020 Jul 29;12(8):2279. doi: 10.3390/nu12082279

Figure 2.

Figure 2

Suppression of tumor development by MeshimaMax in DBMA treated rats. (a) Average numbers of breast tumors developed; (b) Cumulative size (tumor volume) of breast tumors. Data are those at day 206 after MeshimaMax treatment. * P < 0.05 vs Control. Data are mean ± SD, n = 5–6.